Cleared Traditional

Endoluminal Occlusion System-EOS (K150402) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K150402 · Artventive Medical Group, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2015
Decision
219d
Days
Class 2
Risk

K150402 is an FDA 510(k) clearance for the Endoluminal Occlusion System-EOS. Classified as Device, Vascular, For Promoting Embolization (product code KRD), Class II - Special Controls.

Submitted by Artventive Medical Group, Inc. (Carlsbad, US). The FDA issued a Cleared decision on September 25, 2015 after a review of 219 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Artventive Medical Group, Inc. devices

Submission Details

510(k) Number K150402 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 2015
Decision Date September 25, 2015
Days to Decision 219 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
94d slower than avg
Panel avg: 125d · This submission: 219d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KRD Device, Vascular, For Promoting Embolization
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRD Device, Vascular, For Promoting Embolization

All 74
Devices cleared under the same product code (KRD) and FDA review panel - the closest regulatory comparables to K150402.
Nester Embolization Coils, Tornado Embolization Coils
K153778 · Cook Incorporated · May 2016
MReye Embolization Coils
K150931 · Cook Incorporated · Dec 2015
MReye Flipper Detachable Embolization Coil and Delivery System
K150964 · Cook Incorporated · Dec 2015
Retracta Detachable Embolization Coil
K151676 · Cook Incorporated · Jul 2015
Gel-Block 10X embolization pledgets
K143038 · Vascular Solutions, Inc. · Nov 2014
IDC INTERLOCKING DETACHABLE COIL
K141378 · Boston Scientific Corporation · Oct 2014